Intriguingly, the results indicated that the checkpoint gene expression levels of CD274 and PDCD1, which can encode PD-L1 and PD-1 protein inducing the suppression of anti-tumor immunity, were higher in high-risk patients than in low-2risk patients. Here, CD274 is linked to neoplasm.